SFRP1 and neoplasm: In the lung, however, metastatic cells are reactivated by aged fibroblasts through secreted sFRP1, which is an antagonist of Wnt5a, resulting in decreased AXL signaling, enhanced MER activation and tumor cell proliferation [244].